Skip to main content
OpenTrials
Completed

NCT Number: NCT06663579

The Effect of Kangaroo Care Method On The Self-Confıdence and Attachment Levels of Fathers of Preterm Babies

This study was conducted as a randomized controlled experimental type to evaluate the confidence and attachment levels of fathers in baby care whose babies were treated in the neonatal intensive care unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Biruni University

Istanbul, 34010, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For Newborns:

  • Being a newborn treated in the Istanbul Başakşehir Çam and Sakura Hospital Neonatal Intensive Care Unit
  • Gestational age less than 37 weeks
  • Postnatal age between 0-28 days
  • The baby is considered stable by a neonatologist
  • The baby can maintain body temperature during Kangaroo Care
  • Safety is ensured if there is an existing umbilical or central catheter

For fathers:

  • Agreeing to practice Kangaroo Care
  • Having no health condition that would prevent practicing Kangaroo Care
  • Being able to maintain sufficient hygiene conditions for Kangaroo Care
  • Being literate
  • Being able to communicate in Turkish

Exclusion criteria

For babies:

  • Receiving respiratory support
  • Having a chest tube
  • Having a congenital anomaly
  • Using sedative medication
  • Having undergone surgery

For fathers:

  • Not wanting to practice Kangaroo Care
  • Using substances that cause sedation (drugs, alcohol)
  • Having a disease that can be transmitted through skin contact
  • Not agreeing to participate in the study
  • Not living in the same house as the baby

Treatment and study plan

Fathers who practicing kangaroo care

Other

The study group (n=28) It consists of fathers of babies practicing Kangaroo Care with both their mothers and fathers in the neonatal intensive care unit.

Primary outcomes

  1. Paternal-Infant Attachment Scale

    Time frame: This assessment scale will be administered to the father one month following the baby's discharge from the hospital.

    The scale developed to assess father-infant bonding after birth is a 19-item scale. It consists of three subdimensions: 'patience and tolerance,' 'enjoyment in interaction,' and 'love and pride'. Twelve items in the scale are reverse-coded. Higher scores indicate a higher level of bonding. While the original version of the scale consists of 19 items, the Turkish version comprises 18 items. The Cronbach's alpha coefficient of the scale was reported to be 0.81 at 6 months and 0.78 at 12 months.

Secondary outcomes

  1. Karitane Parenting Confidence Scale

    Time frame: This assessment scale will be administered to the father one month following the baby's discharge from the hospital.

    The scale, originally developed by Crncec and colleagues in 2008, was adapted into Turkish by Yılmaz and Oskay in 2021. It is used to assess the self-confidence of parents regarding their parenting abilities and consists of 14 items designed for parents with infants aged 0 to 12 months. The scale includes two sub-dimensions: "Infant Care" and "Parenting Role." Only Item 11 is reverse scored, with the following scoring pattern: 0 = 3; 1 = 2; 2 = 1; 3 = 0. The total score ranges from 0 to 42, with higher scores indicating a more positive outcome and reflecting higher levels of parental self-confidence.

Sponsors and collaborators

Lead sponsor

Biruni University

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 29, 2024
Registry last updated
Apr 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.